{"id":18227,"date":"2023-06-01T16:45:24","date_gmt":"2023-06-01T06:45:24","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=18227"},"modified":"2023-06-01T16:45:24","modified_gmt":"2023-06-01T06:45:24","slug":"atagi-tu-van-ve-viec-su-dung-uu-dai-cua-vac-xin-covid-19-vac-xin-cho-tiem-chich-co-chinh-cho-nguoi-tu-12-tuoi-tro-len","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","title":{"rendered":"ATAGI khuy\u1ebfn c\u00e1o \u01b0u ti\u00ean s\u1eed d\u1ee5ng v\u1eafc xin nh\u1ecb gi\u00e1 COVID-19 \u0111\u1ec3 ti\u00eam ch\u1ee7ng c\u01a1 b\u1ea3n cho ng\u01b0\u1eddi t\u1eeb 12 tu\u1ed5i tr\u1edf l\u00ean"},"content":{"rendered":"<p><span data-contrast=\"auto\">ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines. Whilst safety and immunogenicity data for bivalent vaccines in a primary series is limited, the safety profile when\u00a0used as a booster dose is similar to when original\/ancestral vaccines are used.\u00a0 <\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Individuals aged 12-17 years are recommended to receive BA.4\/5-containing bivalent vaccines for primary vaccination and booster doses.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Individuals aged 18 years and over can receive either BA.1-containing or BA.4\/5-containing vaccines for primary vaccination and booster doses.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li>Individuals aged 12 and over who have commenced their primary course with an original (ancestral) vaccine are recommended to complete the course with a bivalent vaccine.<\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">There are no bivalent vaccines currently available for use in children aged 6 months-11 years and therefore original\/ancestral strain vaccines should continue to be used (noting that booster doses are not recommended for anyone under 5 years of age).<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">There are no changes to who is recommended to receive booster doses. Schedules and intervals between doses also remain unchanged.<\/span><\/p>\n<p><a href=\"https:\/\/www.health.gov.au\/news\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older?language=en\" target=\"_blank\" rel=\"noopener\"><span class=\"TextRun SCXW134655446 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun CommentStart CommentHighlightPipeRest CommentHighlightRest SCXW134655446 BCX0\">ATAGI<\/span><span class=\"NormalTextRun CommentHighlightRest SCXW134655446 BCX0\"> advice\u00a0on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older<\/span><\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ATAGI \u0111\u00e3 xem x\u00e9t b\u1eb1ng ch\u1ee9ng m\u1edbi nh\u1ea5t v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc xin COVID-19 h\u00f3a tr\u1ecb hai. Hi\u1ec7n t\u1ea1i, c\u00e1c c\u00e1 nh\u00e2n t\u1eeb 12 tu\u1ed5i tr\u1edf l\u00ean \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb n\u00ean ti\u00eam v\u1eafc-xin h\u00f3a tr\u1ecb hai \u0111\u1ec3 ti\u00eam v\u1eafc-xin c\u01a1 b\u1ea3n v\u00e0 li\u1ec1u nh\u1eafc l\u1ea1i h\u01a1n l\u00e0 s\u1eed d\u1ee5ng v\u1eafc-xin d\u00f2ng g\u1ed1c\/t\u1ed5 ti\u00ean.<\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10],"tags":[],"class_list":["post-18227","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-tu-van-ve-viec-su-dung-uu-dai-cua-vac-xin-covid-19-vac-xin-cho-tiem-chich-co-chinh-cho-nguoi-tu-12-tuoi-tro-len\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-tu-van-ve-viec-su-dung-uu-dai-cua-vac-xin-covid-19-vac-xin-cho-tiem-chich-co-chinh-cho-nguoi-tu-12-tuoi-tro-len\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-01T06:45:24+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older\",\"datePublished\":\"2023-06-01T06:45:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"},\"wordCount\":232,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\",\"name\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2023-06-01T06:45:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u1eddi khuy\u00ean c\u1ee7a ATAGI v\u1ec1 vi\u1ec7c \u01b0u ti\u00ean s\u1eed d\u1ee5ng v\u1eafc xin COVID-19 h\u00f3a tr\u1ecb hai \u0111\u1ec3 ti\u00eam v\u1eafc xin c\u01a1 b\u1ea3n cho ng\u01b0\u1eddi t\u1eeb 12 tu\u1ed5i tr\u1edf l\u00ean - Trung t\u00e2m Gi\u00e1o d\u1ee5c V\u1eafc xin Melbourne (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-tu-van-ve-viec-su-dung-uu-dai-cua-vac-xin-covid-19-vac-xin-cho-tiem-chich-co-chinh-cho-nguoi-tu-12-tuoi-tro-len\/","og_locale":"vi_VN","og_type":"article","og_title":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)","og_description":"ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines.","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-tu-van-ve-viec-su-dung-uu-dai-cua-vac-xin-covid-19-vac-xin-cho-tiem-chich-co-chinh-cho-nguoi-tu-12-tuoi-tro-len\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2023-06-01T06:45:24+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Alice Black","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older","datePublished":"2023-06-01T06:45:24+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"},"wordCount":232,"articleSection":["Show all","COVID-19","External News"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","name":"L\u1eddi khuy\u00ean c\u1ee7a ATAGI v\u1ec1 vi\u1ec7c \u01b0u ti\u00ean s\u1eed d\u1ee5ng v\u1eafc xin COVID-19 h\u00f3a tr\u1ecb hai \u0111\u1ec3 ti\u00eam v\u1eafc xin c\u01a1 b\u1ea3n cho ng\u01b0\u1eddi t\u1eeb 12 tu\u1ed5i tr\u1edf l\u00ean - Trung t\u00e2m Gi\u00e1o d\u1ee5c V\u1eafc xin Melbourne (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2023-06-01T06:45:24+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"Alice \u0111en","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/alice-black\/"}]}},"modified_by":"Alice Black","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/18227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=18227"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/18227\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=18227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=18227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=18227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}